ClinicalTrials.gg
Not yet recruitingNCT07237152COPE: MTUpdated Nov 19, 2025

Chronic Pain Predictors in Major Trauma

An observational study in Chronic Pain and Limb Fracture, sponsored by University of Nottingham. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2025-11-19.

Sponsored by University of Nottingham · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
450
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 116 studies in Chronic Pain with a site in United Kingdom — 19 open to participants now, 21 under way, none of them phase 3. Chronic Pain · United Kingdom.

Planned enrollment
13th of 47
450 · median 132
Started
2025
with 3 others
Observational
47 of 116
11 open now
Primary completion
2027-10
later than 14 of 20 live
Registered
110th of 116
by date
Lead sponsor
7 of 116
University of Nottingham

Among the 116 studies in Chronic Pain with a site in United Kingdom, this one is the 13th largest by planned enrollment of the 47 observational ones that give a count, is one of 4 that started in 2025, is one of 47 observational ones, reaches primary completion later than 14 of the 20 other live ones, and was the 110th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

19 of the 116 studies in Chronic Pain with a site in United Kingdom are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 16 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 116 studies in Chronic Pain with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this observational study is to learn about who is at risk of developing chronic pain in a major trauma population with at least one limb fracture.

The main question it aims to answer is: which risk factors predict which patients will experience chronic pain following traumatic limb injury.

Participants will answer a baseline questionnaire and two outcome questionnaires about their pain at 3 and 6 months after their injury.

03

Conditions studied

  • Chronic Pain
  • Limb Fracture

Browse trials for

Keywords

  • chronic pain
  • limb fracture
  • risk factors
  • prediction model
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult major trauma patients with a minimum of one limb fracture treated at the East Midlands Major Trauma Centre based at Nottingham University Hospitals NHS Trust

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Aged ≥ 16 Polytrauma patient (multiple injuries affecting multiple body regions or organ systems) Admitted to a UK Major Trauma Centre Minimum of 1 radiologically confirmed traumatic limb fracture Have capacity to provide to participate in the study Have sufficient proficiency in English to provide the required data or be willing to use an approved interpreting service for data collection Recruited within 4 weeks of injury

Exclusion criteria

Exclusion Criteria:

No traumatic limb fracture Patients with a primary or treatment amputation in relation to their limb injury Pathological limb fractures Prisoners No fixed abode

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
450 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Presence of chronic pain

    Assessed using a 11-point numerical rating scale from 0 (no pain) - 10 (worst possible pain).

    Time frame: Reported at baseline, 3 and 6 months post-injury

  2. Severity of chronic pain

    Assessed using a 11-point numerical rating scale from 0 (no pain) - 10 (worst possible pain).

    Time frame: Reported at baseline, 3 and 6 months post-injury

  3. Pain impact

    Assessed using the six-item pain interference index

    Time frame: Reported at baseline, 3 and 6 months post-injury

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Oct 2027, 22 months later.

Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's planned 22 months is close to that.

Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 19, 2025
StartEst.
Dec 2025
Primary completionEst.
Oct 2027
CompletionEst.
Oct 2027
Last update
Nov 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07237152
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Dec 2025 (estimated)
Primary completion
Oct 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Nov 19, 2025

Study contacts

Georgia E Melia, BSc (Hons), MRes
Contact
georgia.melia1@nhs.net
+44 0115 9249924 ext. 87070
Denise Kendrick, Professor
study director · Faculty of Medicine & Health Sciences University of Nottingham
Adam Brooks, FRCS (Gen Surg)
principal investigator · Nottingham University Hospitals NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion